Method of using adenoviral vectors with increased persistencein vivo

Details for Australian Patent Application No. 2004214948 (hide)

Owner GenVec Inc.

Inventors Wickham, Thomas J.; Akiyama, Masaki

Agent Pizzeys

Pub. Number AU-A-2004214948

PCT Pub. Number WO2004/076627

Priority 10/374,271 25.02.03 US

Filing date 18 February 2004

Wipo publication date 10 September 2004

International Classifications

C12N 015/861 Mutation or genetic engineering - Adenoviral vectors

Event Publications

22 September 2005 PCT application entered the National Phase

  PCT publication WO2004/076627 Priority application(s): WO2004/076627

10 May 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004214954-Methods and constructs for evaluation of RNAi targets and effector molecules

2004214938-Glutamate transport modulatory compounds and methods